Galaxy Surfactants Limited reported consolidated results for the quarter and full year ended 31 March 2026, with total revenue for Q4 at Rs 13,150 mn and for FY26 at Rs 52,704 mn. EBITDA for the quarter was Rs 1,219 mn and Rs 4,974 mn for the year, while profit after tax for Q4 was Rs 624 mn and Rs 2,674 mn for FY26. The board said the business remained resilient despite a disrupted operating environment.

Q4 EBITDA declined year-on-year and EBITDA per metric tonne (t) was Rs 20,113 versus Rs 21,715, reflecting pass-through of cost changes and an improved specialty mix. Management attributed margin pressure to global supply chain and logistics disruptions and higher input costs, with disciplined cost control offsetting some impact. Pricing actions and customer partnerships were cited as near-term levers.

India delivered high single-digit volume growth in the quarter and low single-digit growth for the year, driven by specialty care and steady performance segment demand. AMET volumes fell in the mid-teens in Q4 owing to logistics and raw material constraints, while the rest of the world declined by high single digits in Q4 but grew four per cent for the year. The Americas improved sequentially after tariff reversals and stronger specialty demand.

Performance surfactant volumes were down by high single digits in Q4, while specialty care grew by a similar margin, leaving overall volumes flat. Segment revenue in Q4 comprised Rs 8,173 mn from performance surfactants and Rs 4,976 mn from specialty care, with full-year contributions of Rs 33,408 mn and Rs 19,296 mn respectively. Statutory adjustments included Rs 119 mn related to new labour codes.

The company highlighted a portfolio of over 215 product grades and a customer base of multinational and regional FMCG brands, supported by five manufacturing sites in India, one in Egypt and one in the United States. Management said focus on specialty growth, agile pricing and a diversified global footprint should support sequential improvement in coming quarters, subject to risks noted in standard disclaimers.